
Bristol Myers Squibb Integrates Anthropic's Claude AI for Drug Discovery
Bristol Myers Squibb is working with Anthropic to use Claude AI in drug discovery and other business areas. This partnership may help BMS choose which projects to focus on by predicting what will work before spending resources. Claude's tasks include helping with research, making documents for trials, and solving problems in manufacturing. Experts suggest that using AI like this might make drug discovery faster and lower costs, but the exact benefits are still uncertain. The results of this partnership could become clearer as BMS measures how well Claude improves their work and how quickly new projects move forward.
















































